Visalytics
Visalytics
approved EB-2 (NIW)

Life Science Research Professional

Molecular Biology · India · 2025-12-23

Processing Time
162 days
Decision Date
2025-12-23
Location
California
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to apply advanced molecular biology and multi-omics approaches to develop novel small-molecule inhibitors and RNA-based therapeutics. This work focuses on precisely targeting dysregulated signaling pathways to create therapeutic strategies for cancers, complex genetic disorders, and pathogen-induced infections.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The work addresses serious human diseases and aligns with public health priorities and major biomedical funding sources.

2 Well-positioned to Advance the Endeavor Met

The petitioner's Ph.D. and record of peer-reviewed publications and citations demonstrate the necessary expertise and influence in the field.

3 Balance of Factors Met

USCIS determined that the petitioner's contributions to molecular biology and therapeutic discovery justify a waiver of the job offer requirement.

Why This Petition Was Approved

The petition was approved based on the petitioner's Ph.D. in biochemistry, microbiology, and molecular biology and a record of 3 peer-reviewed journal articles and 1 preprint with 108 citations. The case demonstrated national importance through alignment with major U.S. biomedical funding sources and included 2 expert recommendation letters satisfying the Dhanasar prongs.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Dependent
Grants
Government Alignment

Similar Cases

Others

Biotechnology · China

WeGreened EB-2 (NIW) approved
California 318 days 2025-12-12
The petitioner proposes to use small molecules in proteomic and multi-omic techniques to advance the understanding of cancer-relevant molecular pathways. This work focuses on identifying and characterizing mechanisms central to disease progression to support basic cancer research and treatment development.
View Case

Scientist

Biotechnology · Albania

WeGreened EB-2 (NIW) approved
California 64 days 2025-02-10
The petitioner proposes to continue her research in molecular biology, specifically focusing on identifying drug targets and their mechanisms of action in complex biological samples. Her work utilizes proteogenomic approaches to elucidate the relationship between genetic mutations and protein functions in breast cancer. This research is intended to enhance the understanding of disease mechanisms and inform the development of targeted therapies for cancer, metabolic disorders, and neurodegenerative conditions.
View Case

Research Scientist

Biotechnology · Iran

WeGreened EB-2 (NIW) approved
Maryland 470 days 2025-02-28
The petitioner proposes to continue research in molecular biology focusing on the roles of specific proteins and signaling pathways in cancer development. The work involves studying compounds that disrupt survival signals in cancer cells to design highly effective, targeted therapies. The goal is to improve patient survival rates and enhance the precision of cancer treatments globally.
View Case

Postdoctoral Researcher

Biotechnology · China

WeGreened EB-2 (NIW) rfe approved
New Jersey 103 days 2025-07-17
The petitioner proposes to continue characterizing the genetic, molecular, and biological mechanisms underlying complex diseases such as cancer, neuronal disorders, and psychiatric conditions. Her work integrates bioinformatics, multi-omics analysis, and artificial intelligence with wet-lab validation to support early detection and personalized medical strategies.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from India

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-12-23.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 162 days
Criteria Met 3 / 3
Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,814
Success Rate 53.6%
Sustained 2,046
Dismissed 1,672

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in India All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist